NOVT.NASDAQNovanta INC

Form 4: Novanta CEO Matthijs Glastra Executes Stock Sale

Sentiment:

Statement of Changes in Beneficial Ownership


Novanta Inc. CEO Matthijs Glastra sold 6,500 shares of common stock via a pre-established Rule 10b5-1 trading plan.

Summary

  • CEO Matthijs Glastra sold 6,500 shares of Novanta Inc. (NOVT) common stock on April 17, 2026.
  • The shares were sold at a weighted-average price of $130.05 per share.
  • The transaction was conducted under a Rule 10b5-1 trading plan adopted on September 11, 2025.
  • Following the sale, the CEO maintains direct ownership of 56,761 shares and indirect ownership of 54,382 shares through a family trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was pre-planned and represents a small portion of the executive's total holdings.

Positives

  • The sale was executed through a pre-planned Rule 10b5-1 program, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.

Negatives

  • The transaction represents a reduction in the CEO's direct equity stake in the company.

Risks

  • Insider selling can sometimes be perceived by the market as a signal that the stock price has reached a near-term peak.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales via 10b5-1 plans are routine corporate governance events and generally do not reflect a change in management's outlook on the company's long-term prospects.

Comparison to Industry Standards

  • The use of Rule 10b5-1 plans is the industry standard for executives to manage personal liquidity while maintaining compliance with SEC regulations.

Related Party Transactions

  • The transaction involved a trust for which the reporting person's spouse is a trustee.

Stakeholder Impact

  • Minimal impact expected as the sale was conducted via a pre-established, automated trading plan.

Next Steps

  • No future actions or milestones were disclosed in this filing.

Key Dates

DateDescription
09/11/2025Date the Rule 10b5-1 trading plan was adopted.
04/17/2026Date of the reported stock sale transaction.
04/21/2026Date the Form 4 was signed and filed.

Keywords

Novanta, NOVT, Insider Trading, Form 4, Matthijs Glastra, Stock Sale, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.